A Randomized Study of Safety and Efficacy of Two Doses of Ambrisentan to Treat Pulmonary Arterial Hypertension in Pediatric Patients Aged 8 Years up to 18 Years
The Journal of Pediatrics: X（2020）
摘要
ClinicalTrials.gov: NCT01332331.
更多查看译文
关键词
clinical trial,endothelin receptor antagonist,cardiovascular disease,treatment,children
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要